the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia

NCT05851105 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

3

Enrollment

INDUSTRY

Sponsor class

Conditions

α-thalassemia

Interventions

BIOLOGICAL: α-globin restored autologous hematopoietic stem cells

Sponsor

Shenzhen Hemogen